Pasithea Therapeutics Corp. Quarterly Nonoperating Income (Expense) in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Pasithea Therapeutics Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2021 to Q3 2024.
  • Pasithea Therapeutics Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.77K, a 97.3% decline year-over-year.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.77K -$172K -97.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $78.8K -$152K -65.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $180K +$233K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $177K +$512K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $231K -$191K -45.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$53.3K -$884K -106% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 -$335K -$82.8K -32.8% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $422K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $830K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q3 2021 -$253K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.